nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Citrulline—NOS3—prostate cancer	0.36	1	CbGaD
L-Citrulline—NOS1—Doxorubicin—prostate cancer	0.169	0.429	CbGbCtD
L-Citrulline—NOS3—Doxorubicin—prostate cancer	0.112	0.285	CbGbCtD
L-Citrulline—NOS2—Doxorubicin—prostate cancer	0.112	0.285	CbGbCtD
L-Citrulline—NOS1—penis—prostate cancer	0.00988	0.0978	CbGeAlD
L-Citrulline—NOS3—penis—prostate cancer	0.00751	0.0743	CbGeAlD
L-Citrulline—PADI3—prostate gland—prostate cancer	0.00626	0.0619	CbGeAlD
L-Citrulline—PADI3—seminal vesicle—prostate cancer	0.00529	0.0524	CbGeAlD
L-Citrulline—PADI1—urethra—prostate cancer	0.00502	0.0497	CbGeAlD
L-Citrulline—PADI2—prostate gland—prostate cancer	0.00437	0.0432	CbGeAlD
L-Citrulline—PADI3—renal system—prostate cancer	0.00427	0.0422	CbGeAlD
L-Citrulline—DDAH2—prostate gland—prostate cancer	0.00366	0.0362	CbGeAlD
L-Citrulline—DDAH1—prostate gland—prostate cancer	0.00353	0.0349	CbGeAlD
L-Citrulline—DDAH2—seminal vesicle—prostate cancer	0.0031	0.0307	CbGeAlD
L-Citrulline—PADI4—bone marrow—prostate cancer	0.00302	0.0299	CbGeAlD
L-Citrulline—DDAH1—epithelium—prostate cancer	0.00259	0.0257	CbGeAlD
L-Citrulline—DDAH2—urethra—prostate cancer	0.00245	0.0243	CbGeAlD
L-Citrulline—DDAH1—renal system—prostate cancer	0.00241	0.0238	CbGeAlD
L-Citrulline—NOS1—prostate gland—prostate cancer	0.00236	0.0234	CbGeAlD
L-Citrulline—OTC—testis—prostate cancer	0.00226	0.0224	CbGeAlD
L-Citrulline—PADI2—bone marrow—prostate cancer	0.00225	0.0223	CbGeAlD
L-Citrulline—PADI2—testis—prostate cancer	0.00193	0.0191	CbGeAlD
L-Citrulline—DDAH2—bone marrow—prostate cancer	0.00189	0.0187	CbGeAlD
L-Citrulline—ASS1—prostate gland—prostate cancer	0.0018	0.0178	CbGeAlD
L-Citrulline—NOS3—prostate gland—prostate cancer	0.00179	0.0178	CbGeAlD
L-Citrulline—NOS1—epithelium—prostate cancer	0.00173	0.0172	CbGeAlD
L-Citrulline—OTC—lymph node—prostate cancer	0.00164	0.0162	CbGeAlD
L-Citrulline—ASS1—Norethindrone—Ethinyl Estradiol—prostate cancer	0.00162	1	CbGdCrCtD
L-Citrulline—DDAH2—testis—prostate cancer	0.00161	0.016	CbGeAlD
L-Citrulline—NOS1—renal system—prostate cancer	0.00161	0.0159	CbGeAlD
L-Citrulline—DDAH1—testis—prostate cancer	0.00156	0.0154	CbGeAlD
L-Citrulline—ASS1—seminal vesicle—prostate cancer	0.00152	0.0151	CbGeAlD
L-Citrulline—PADI2—lymph node—prostate cancer	0.0014	0.0138	CbGeAlD
L-Citrulline—ASS1—epithelium—prostate cancer	0.00132	0.0131	CbGeAlD
L-Citrulline—NOS3—epithelium—prostate cancer	0.00132	0.013	CbGeAlD
L-Citrulline—ASS1—renal system—prostate cancer	0.00123	0.0121	CbGeAlD
L-Citrulline—NOS3—renal system—prostate cancer	0.00122	0.0121	CbGeAlD
L-Citrulline—ASS1—urethra—prostate cancer	0.00121	0.0119	CbGeAlD
L-Citrulline—DDAH2—lymph node—prostate cancer	0.00117	0.0116	CbGeAlD
L-Citrulline—DDAH1—lymph node—prostate cancer	0.00113	0.0112	CbGeAlD
L-Citrulline—NOS1—testis—prostate cancer	0.00104	0.0103	CbGeAlD
L-Citrulline—ASS1—testis—prostate cancer	0.000793	0.00785	CbGeAlD
L-Citrulline—NOS3—testis—prostate cancer	0.00079	0.00782	CbGeAlD
L-Citrulline—Glutathione—GSTK1—prostate cancer	0.000779	0.0958	CrCbGaD
L-Citrulline—L-Lysine—SLC7A1—prostate cancer	0.000668	0.0822	CrCbGaD
L-Citrulline—L-Cysteine—CSAD—prostate cancer	0.00065	0.08	CrCbGaD
L-Citrulline—L-Arginine—SLC7A1—prostate cancer	0.000634	0.078	CrCbGaD
L-Citrulline—Glutathione—GSTM3—prostate cancer	0.00059	0.0726	CrCbGaD
L-Citrulline—ASS1—lymph node—prostate cancer	0.000575	0.00569	CbGeAlD
L-Citrulline—NOS3—lymph node—prostate cancer	0.000573	0.00567	CbGeAlD
L-Citrulline—L-Ornithine—SLC7A1—prostate cancer	0.000506	0.0623	CrCbGaD
L-Citrulline—Glutathione—GSTA3—prostate cancer	0.000447	0.055	CrCbGaD
L-Citrulline—L-Glutamine—QARS—prostate cancer	0.000425	0.0523	CrCbGaD
L-Citrulline—Glutathione—GSTA4—prostate cancer	0.000409	0.0503	CrCbGaD
L-Citrulline—L-Arginine—ARG2—prostate cancer	0.000391	0.0482	CrCbGaD
L-Citrulline—Glutathione—GPX3—prostate cancer	0.00038	0.0468	CrCbGaD
L-Citrulline—Glutathione—GSTO1—prostate cancer	0.000339	0.0417	CrCbGaD
L-Citrulline—L-Ornithine—ARG2—prostate cancer	0.000313	0.0385	CrCbGaD
L-Citrulline—Glutathione—GGT1—prostate cancer	0.00031	0.0381	CrCbGaD
L-Citrulline—Glutathione—GSTA1—prostate cancer	0.000264	0.0324	CrCbGaD
L-Citrulline—Glutathione—HPGDS—prostate cancer	0.00023	0.0283	CrCbGaD
L-Citrulline—Glutathione—GSTA2—prostate cancer	0.000205	0.0253	CrCbGaD
L-Citrulline—L-Arginine—NOS3—prostate cancer	0.00015	0.0185	CrCbGaD
L-Citrulline—Glutathione—GSTT1—prostate cancer	0.000132	0.0162	CrCbGaD
L-Citrulline—Glutathione—GSTM1—prostate cancer	0.000113	0.0138	CrCbGaD
L-Citrulline—Glutathione—GSTP1—prostate cancer	0.000104	0.0128	CrCbGaD
L-Citrulline—L-Methionine—MTHFR—prostate cancer	8.7e-05	0.0107	CrCbGaD
L-Citrulline—NOS3—Metabolism—PRKACB—prostate cancer	1.36e-05	0.000101	CbGpPWpGaD
L-Citrulline—ASS1—Metabolism—PIK3CD—prostate cancer	1.36e-05	0.0001	CbGpPWpGaD
L-Citrulline—NOS1—Disease—EGF—prostate cancer	1.36e-05	0.0001	CbGpPWpGaD
L-Citrulline—NOS1—Disease—IRS1—prostate cancer	1.36e-05	0.0001	CbGpPWpGaD
L-Citrulline—NOS2—Disease—PDGFRB—prostate cancer	1.36e-05	0.0001	CbGpPWpGaD
L-Citrulline—NOS2—Hemostasis—EP300—prostate cancer	1.35e-05	9.98e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—CYP17A1—prostate cancer	1.35e-05	9.95e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—CASP9—prostate cancer	1.34e-05	9.94e-05	CbGpPWpGaD
L-Citrulline—NOS3—Hemostasis—JAK2—prostate cancer	1.34e-05	9.9e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—GNG5—prostate cancer	1.33e-05	9.87e-05	CbGpPWpGaD
L-Citrulline—NOS1—Hemostasis—PIK3CA—prostate cancer	1.32e-05	9.78e-05	CbGpPWpGaD
L-Citrulline—NOS1—Disease—GSK3B—prostate cancer	1.32e-05	9.73e-05	CbGpPWpGaD
L-Citrulline—NOS2—Hemostasis—SRC—prostate cancer	1.31e-05	9.7e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—ERCC2—prostate cancer	1.31e-05	9.68e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—PRKCQ—prostate cancer	1.3e-05	9.63e-05	CbGpPWpGaD
L-Citrulline—NOS1—Disease—INS—prostate cancer	1.3e-05	9.6e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—NCOA2—prostate cancer	1.28e-05	9.49e-05	CbGpPWpGaD
L-Citrulline—ASS1—Metabolism—NOS3—prostate cancer	1.28e-05	9.49e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—ERBB3—prostate cancer	1.28e-05	9.47e-05	CbGpPWpGaD
L-Citrulline—NOS1—Hemostasis—TP53—prostate cancer	1.28e-05	9.46e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—FGFR2—prostate cancer	1.28e-05	9.46e-05	CbGpPWpGaD
L-Citrulline—NOS2—Hemostasis—VEGFA—prostate cancer	1.28e-05	9.45e-05	CbGpPWpGaD
L-Citrulline—NOS1—Disease—CREBBP—prostate cancer	1.27e-05	9.4e-05	CbGpPWpGaD
L-Citrulline—NOS3—Hemostasis—PIK3CB—prostate cancer	1.27e-05	9.4e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—FGF10—prostate cancer	1.24e-05	9.15e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—MTHFR—prostate cancer	1.23e-05	9.1e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—TERT—prostate cancer	1.23e-05	9.08e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—SLC5A5—prostate cancer	1.22e-05	9.05e-05	CbGpPWpGaD
L-Citrulline—NOS1—Disease—MAP2K1—prostate cancer	1.21e-05	8.97e-05	CbGpPWpGaD
L-Citrulline—NOS1—Disease—PIK3CD—prostate cancer	1.21e-05	8.91e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—CYP2E1—prostate cancer	1.2e-05	8.84e-05	CbGpPWpGaD
L-Citrulline—NOS1—Disease—SERPINE1—prostate cancer	1.19e-05	8.82e-05	CbGpPWpGaD
L-Citrulline—ASS1—Metabolism—PIK3CB—prostate cancer	1.18e-05	8.76e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—NQO1—prostate cancer	1.18e-05	8.74e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—TGFBR2—prostate cancer	1.18e-05	8.7e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—HIF1A—prostate cancer	1.17e-05	8.68e-05	CbGpPWpGaD
L-Citrulline—ASS1—Metabolism—PTGS2—prostate cancer	1.17e-05	8.68e-05	CbGpPWpGaD
L-Citrulline—NOS2—Hemostasis—TGFB1—prostate cancer	1.17e-05	8.67e-05	CbGpPWpGaD
L-Citrulline—NOS3—Hemostasis—IL2—prostate cancer	1.17e-05	8.63e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—TH—prostate cancer	1.17e-05	8.61e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—PTHLH—prostate cancer	1.16e-05	8.59e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—TGFBR1—prostate cancer	1.16e-05	8.59e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—ITPR1—prostate cancer	1.16e-05	8.56e-05	CbGpPWpGaD
L-Citrulline—NOS1—Disease—FGF2—prostate cancer	1.15e-05	8.54e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—CYP3A4—prostate cancer	1.15e-05	8.52e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—AKR1C3—prostate cancer	1.14e-05	8.45e-05	CbGpPWpGaD
L-Citrulline—NOS1—Disease—NOS3—prostate cancer	1.14e-05	8.42e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—PRKACB—prostate cancer	1.14e-05	8.41e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—CAV1—prostate cancer	1.14e-05	8.4e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—CYP1B1—prostate cancer	1.13e-05	8.38e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—THBS1—prostate cancer	1.11e-05	8.2e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—PPP3CA—prostate cancer	1.11e-05	8.2e-05	CbGpPWpGaD
L-Citrulline—NOS1—Disease—JAK2—prostate cancer	1.11e-05	8.18e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—GGT1—prostate cancer	1.1e-05	8.11e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—ANXA1—prostate cancer	1.09e-05	8.08e-05	CbGpPWpGaD
L-Citrulline—NOS2—Hemostasis—KRAS—prostate cancer	1.09e-05	8.03e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—NCOA1—prostate cancer	1.08e-05	7.99e-05	CbGpPWpGaD
L-Citrulline—NOS1—Hemostasis—AKT1—prostate cancer	1.08e-05	7.99e-05	CbGpPWpGaD
L-Citrulline—NOS1—Disease—MDM2—prostate cancer	1.08e-05	7.99e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—PRKCZ—prostate cancer	1.07e-05	7.93e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—BAD—prostate cancer	1.07e-05	7.9e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—CYP19A1—prostate cancer	1.07e-05	7.88e-05	CbGpPWpGaD
L-Citrulline—NOS1—Disease—ERBB2—prostate cancer	1.07e-05	7.87e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—LPL—prostate cancer	1.06e-05	7.85e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—PDGFRB—prostate cancer	1.05e-05	7.78e-05	CbGpPWpGaD
L-Citrulline—NOS1—Disease—PIK3CB—prostate cancer	1.05e-05	7.77e-05	CbGpPWpGaD
L-Citrulline—NOS3—Hemostasis—EP300—prostate cancer	1.05e-05	7.75e-05	CbGpPWpGaD
L-Citrulline—OTC—Metabolism—PIK3CA—prostate cancer	1.04e-05	7.7e-05	CbGpPWpGaD
L-Citrulline—NOS1—Disease—PTGS2—prostate cancer	1.04e-05	7.7e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—FGFR4—prostate cancer	1.04e-05	7.66e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—PARP1—prostate cancer	1.04e-05	7.66e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—APC—prostate cancer	1.03e-05	7.65e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—RXRA—prostate cancer	1.03e-05	7.6e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—CALCA—prostate cancer	1.02e-05	7.57e-05	CbGpPWpGaD
L-Citrulline—ASS1—Metabolism—PTEN—prostate cancer	1.02e-05	7.57e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—IRS1—prostate cancer	1.02e-05	7.56e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—EGF—prostate cancer	1.02e-05	7.56e-05	CbGpPWpGaD
L-Citrulline—NOS3—Hemostasis—SRC—prostate cancer	1.02e-05	7.53e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—ERCC2—prostate cancer	1.02e-05	7.52e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—CXCL12—prostate cancer	1e-05	7.39e-05	CbGpPWpGaD
L-Citrulline—NOS2—Hemostasis—PIK3CA—prostate cancer	9.98e-06	7.38e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—ERBB3—prostate cancer	9.95e-06	7.35e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—FGFR2—prostate cancer	9.93e-06	7.34e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—GSK3B—prostate cancer	9.93e-06	7.34e-05	CbGpPWpGaD
L-Citrulline—NOS3—Hemostasis—VEGFA—prostate cancer	9.93e-06	7.34e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—COMT—prostate cancer	9.91e-06	7.32e-05	CbGpPWpGaD
L-Citrulline—NOS1—Disease—CDKN1B—prostate cancer	9.87e-06	7.29e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—GSTP1—prostate cancer	9.86e-06	7.29e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—INS—prostate cancer	9.8e-06	7.24e-05	CbGpPWpGaD
L-Citrulline—ASS1—Metabolism—EP300—prostate cancer	9.76e-06	7.22e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—ITPR1—prostate cancer	9.7e-06	7.17e-05	CbGpPWpGaD
L-Citrulline—NOS2—Hemostasis—TP53—prostate cancer	9.66e-06	7.14e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—CREBBP—prostate cancer	9.59e-06	7.09e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—MTHFR—prostate cancer	9.56e-06	7.07e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—TERT—prostate cancer	9.54e-06	7.05e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—CASP9—prostate cancer	9.42e-06	6.96e-05	CbGpPWpGaD
L-Citrulline—NOS1—Disease—CTNNB1—prostate cancer	9.32e-06	6.89e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—TYMS—prostate cancer	9.17e-06	6.78e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—MAP2K1—prostate cancer	9.16e-06	6.77e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—PRKCQ—prostate cancer	9.12e-06	6.74e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—NGFR—prostate cancer	9.12e-06	6.74e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—HIF1A—prostate cancer	9.12e-06	6.74e-05	CbGpPWpGaD
L-Citrulline—NOS3—Hemostasis—TGFB1—prostate cancer	9.11e-06	6.73e-05	CbGpPWpGaD
L-Citrulline—NOS1—Disease—CDKN1A—prostate cancer	9.1e-06	6.73e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—PIK3CD—prostate cancer	9.1e-06	6.72e-05	CbGpPWpGaD
L-Citrulline—NOS1—Disease—PTEN—prostate cancer	9.08e-06	6.71e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—GSTM1—prostate cancer	9.06e-06	6.7e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—MAP3K7—prostate cancer	9.02e-06	6.66e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—SERPINE1—prostate cancer	9e-06	6.65e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—LPL—prostate cancer	8.89e-06	6.57e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—CAV1—prostate cancer	8.82e-06	6.52e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—FGF2—prostate cancer	8.71e-06	6.44e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—FGF10—prostate cancer	8.67e-06	6.41e-05	CbGpPWpGaD
L-Citrulline—NOS1—Disease—EP300—prostate cancer	8.66e-06	6.4e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—CYP1A1—prostate cancer	8.59e-06	6.35e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—NOS3—prostate cancer	8.59e-06	6.35e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—ADRB2—prostate cancer	8.58e-06	6.34e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—ERCC2—prostate cancer	8.52e-06	6.3e-05	CbGpPWpGaD
L-Citrulline—OTC—Metabolism—AKT1—prostate cancer	8.51e-06	6.29e-05	CbGpPWpGaD
L-Citrulline—NOS3—Hemostasis—KRAS—prostate cancer	8.44e-06	6.24e-05	CbGpPWpGaD
L-Citrulline—NOS1—Disease—SRC—prostate cancer	8.42e-06	6.23e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—VAV3—prostate cancer	8.36e-06	6.18e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—JAK2—prostate cancer	8.35e-06	6.17e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—BAD—prostate cancer	8.3e-06	6.13e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—TGFBR2—prostate cancer	8.25e-06	6.09e-05	CbGpPWpGaD
L-Citrulline—NOS2—Hemostasis—AKT1—prostate cancer	8.16e-06	6.03e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—MDM2—prostate cancer	8.15e-06	6.02e-05	CbGpPWpGaD
L-Citrulline—NOS1—Disease—STAT3—prostate cancer	8.12e-06	6e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—ITPR1—prostate cancer	8.11e-06	6e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—ERBB2—prostate cancer	8.03e-06	5.94e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—APC—prostate cancer	8.03e-06	5.94e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—MTHFR—prostate cancer	8.01e-06	5.92e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—IRS1—prostate cancer	7.94e-06	5.87e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—EGF—prostate cancer	7.94e-06	5.87e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—PIK3CB—prostate cancer	7.93e-06	5.86e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—PPARA—prostate cancer	7.86e-06	5.81e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—PTGS2—prostate cancer	7.86e-06	5.81e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—IGF1R—prostate cancer	7.76e-06	5.73e-05	CbGpPWpGaD
L-Citrulline—NOS3—Hemostasis—PIK3CA—prostate cancer	7.75e-06	5.73e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—GSK3B—prostate cancer	7.71e-06	5.7e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—INS—prostate cancer	7.61e-06	5.62e-05	CbGpPWpGaD
L-Citrulline—NOS1—Disease—MYC—prostate cancer	7.55e-06	5.58e-05	CbGpPWpGaD
L-Citrulline—NOS1—Disease—TGFB1—prostate cancer	7.53e-06	5.57e-05	CbGpPWpGaD
L-Citrulline—NOS3—Hemostasis—TP53—prostate cancer	7.5e-06	5.54e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—CREBBP—prostate cancer	7.45e-06	5.51e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—CDKN1B—prostate cancer	7.44e-06	5.5e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—LPL—prostate cancer	7.44e-06	5.5e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—CAV1—prostate cancer	7.39e-06	5.46e-05	CbGpPWpGaD
L-Citrulline—NOS1—Disease—EGFR—prostate cancer	7.38e-06	5.46e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—PDGFRB—prostate cancer	7.37e-06	5.45e-05	CbGpPWpGaD
L-Citrulline—ASS1—Metabolism—PIK3CA—prostate cancer	7.22e-06	5.34e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—ITGB3—prostate cancer	7.18e-06	5.31e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—MAP2K1—prostate cancer	7.11e-06	5.26e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—PIK3CD—prostate cancer	7.06e-06	5.22e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—CTNNB1—prostate cancer	7.03e-06	5.2e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—SERPINE1—prostate cancer	6.99e-06	5.16e-05	CbGpPWpGaD
L-Citrulline—NOS1—Disease—KRAS—prostate cancer	6.97e-06	5.16e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—ERBB3—prostate cancer	6.97e-06	5.15e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—FGFR2—prostate cancer	6.96e-06	5.14e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—CDKN1A—prostate cancer	6.87e-06	5.08e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—PTEN—prostate cancer	6.85e-06	5.06e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—FGF2—prostate cancer	6.76e-06	5e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—PIK3CG—prostate cancer	6.73e-06	4.97e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—TERT—prostate cancer	6.68e-06	4.94e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—EP300—prostate cancer	6.53e-06	4.83e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—JAK2—prostate cancer	6.48e-06	4.79e-05	CbGpPWpGaD
L-Citrulline—NOS1—Disease—PIK3CA—prostate cancer	6.41e-06	4.74e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—HIF1A—prostate cancer	6.39e-06	4.72e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—INS—prostate cancer	6.37e-06	4.71e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—SRC—prostate cancer	6.35e-06	4.7e-05	CbGpPWpGaD
L-Citrulline—NOS3—Hemostasis—AKT1—prostate cancer	6.33e-06	4.68e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—MDM2—prostate cancer	6.33e-06	4.68e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—CREBBP—prostate cancer	6.24e-06	4.61e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—ERBB2—prostate cancer	6.24e-06	4.61e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—LEP—prostate cancer	6.23e-06	4.61e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—CAV1—prostate cancer	6.18e-06	4.57e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—PIK3CB—prostate cancer	6.16e-06	4.55e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—STAT3—prostate cancer	6.13e-06	4.53e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—KDR—prostate cancer	6.11e-06	4.51e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—PTGS2—prostate cancer	6.1e-06	4.51e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—ESR1—prostate cancer	5.95e-06	4.4e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—PIK3CD—prostate cancer	5.92e-06	4.37e-05	CbGpPWpGaD
L-Citrulline—ASS1—Metabolism—AKT1—prostate cancer	5.9e-06	4.36e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—BAD—prostate cancer	5.81e-06	4.29e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—CDKN1B—prostate cancer	5.78e-06	4.27e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—MYC—prostate cancer	5.69e-06	4.21e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—TGFB1—prostate cancer	5.68e-06	4.2e-05	CbGpPWpGaD
L-Citrulline—NOS1—Disease—IL6—prostate cancer	5.67e-06	4.19e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—PIK3CG—prostate cancer	5.63e-06	4.16e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—APC—prostate cancer	5.63e-06	4.16e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—EGFR—prostate cancer	5.57e-06	4.12e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—EGF—prostate cancer	5.56e-06	4.11e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—IRS1—prostate cancer	5.56e-06	4.11e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—CTNNB1—prostate cancer	5.46e-06	4.03e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—GSK3B—prostate cancer	5.4e-06	3.99e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—CDKN1A—prostate cancer	5.33e-06	3.94e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—INS—prostate cancer	5.33e-06	3.94e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—PTEN—prostate cancer	5.32e-06	3.93e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—KRAS—prostate cancer	5.26e-06	3.89e-05	CbGpPWpGaD
L-Citrulline—NOS1—Disease—AKT1—prostate cancer	5.23e-06	3.87e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—CREBBP—prostate cancer	5.22e-06	3.86e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—PIK3CB—prostate cancer	5.16e-06	3.81e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—IGF1—prostate cancer	5.15e-06	3.81e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—PTGS2—prostate cancer	5.11e-06	3.78e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—EP300—prostate cancer	5.07e-06	3.75e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—MAP2K1—prostate cancer	4.98e-06	3.68e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—PIK3CD—prostate cancer	4.95e-06	3.66e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—SRC—prostate cancer	4.93e-06	3.65e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—SERPINE1—prostate cancer	4.89e-06	3.62e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—PIK3CA—prostate cancer	4.83e-06	3.57e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—STAT3—prostate cancer	4.76e-06	3.52e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—FGF2—prostate cancer	4.74e-06	3.5e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—JAK2—prostate cancer	4.54e-06	3.36e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—PTEN—prostate cancer	4.46e-06	3.29e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—MDM2—prostate cancer	4.43e-06	3.28e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—MYC—prostate cancer	4.42e-06	3.27e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—TGFB1—prostate cancer	4.41e-06	3.26e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—ERBB2—prostate cancer	4.37e-06	3.23e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—EGFR—prostate cancer	4.32e-06	3.2e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—PIK3CB—prostate cancer	4.31e-06	3.19e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—IL6—prostate cancer	4.28e-06	3.16e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—EP300—prostate cancer	4.25e-06	3.14e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—CXCL8—prostate cancer	4.14e-06	3.06e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—KRAS—prostate cancer	4.09e-06	3.02e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—CDKN1B—prostate cancer	4.05e-06	2.99e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—CASP3—prostate cancer	3.97e-06	2.93e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—IL2—prostate cancer	3.96e-06	2.93e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—AKT1—prostate cancer	3.95e-06	2.92e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—CCND1—prostate cancer	3.86e-06	2.85e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—CTNNB1—prostate cancer	3.82e-06	2.83e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—PIK3CA—prostate cancer	3.75e-06	2.77e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—MMP9—prostate cancer	3.75e-06	2.77e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—CDKN1A—prostate cancer	3.73e-06	2.76e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—PTEN—prostate cancer	3.73e-06	2.75e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—EP300—prostate cancer	3.55e-06	2.63e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—SRC—prostate cancer	3.45e-06	2.55e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—VEGFA—prostate cancer	3.36e-06	2.49e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—STAT3—prostate cancer	3.33e-06	2.46e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—IL6—prostate cancer	3.32e-06	2.46e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—PIK3CA—prostate cancer	3.14e-06	2.32e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—MYC—prostate cancer	3.1e-06	2.29e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—TGFB1—prostate cancer	3.09e-06	2.28e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—AKT1—prostate cancer	3.07e-06	2.27e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—EGFR—prostate cancer	3.03e-06	2.24e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—KRAS—prostate cancer	2.86e-06	2.11e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—PIK3CA—prostate cancer	2.63e-06	1.94e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—AKT1—prostate cancer	2.57e-06	1.9e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—TP53—prostate cancer	2.54e-06	1.88e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—IL6—prostate cancer	2.33e-06	1.72e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—AKT1—prostate cancer	2.15e-06	1.59e-05	CbGpPWpGaD
